retatrutide phase 3 results october 2025 What caught my attention wasn't just the number. It was what the number represents. New trial data for showed an average weight loss of 28.3% at the highest dose What Is Retatrutide? Inside the

These discoveries have revolutionised how we approach obesity management, providing new hope to patients struggling with traditional weight-loss methods

Microparticles can be formulated into diverse dosage forms such as dry powders, injectable suspensions (e.g., microspheres and liposomes), and are suitable for multiple routes of administration, including oral, pulmonary, and parenteral delivery, as summarized in Table 1B

Recent advances in clinical practice challenges and opportunities in the management of obesity

Broad, tailing, or shouldered peaks suggest contamination or degradation

Their benefits now extend well beyond glycemic control and weight loss, with growing evidence supporting their use in the management of steatosis liver disease, obstructive sleep apnea, cardiovascular disease, and chronic kidney disease

Retatrutide carries the same black box warning as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound)